Effect of methylprednisolone on coagulation
- PMID: 12656434
- PMCID: PMC2608443
Effect of methylprednisolone on coagulation
Abstract
This in vitro study examined the effects of methylprednisolone on coagulation status. Venous blood samples were collected from 12 adult subjects including healthy volunteers and patients presenting to the emergency department and analyzed for coagulation changes using the modified recalcification time (MRT) test prior to and after the addition of methylprednisolone. Mean +/- SD MRT control values before the addition of methylprednisolone (MRTC) and after (MRTCP) were 5.4 +/- 1.5 and 5.7 +/- 1.3 minutes, respectively. The MRT saline values prior to treatment with methylprednisolone (MRTS) and after (MRTSP) were 5.6 +/- 1.2 and 5.4 +/- 1.1 minutes, respectively. The MRT endotoxin prior to the introduction of steroid (MRTE) and after its addition (MRTEP) were 3.8 +/- 0.8 and 5.2 +/- 1.4 minutes, respectively. The MRTE values in the presence of methylprednisolone were significantly different between groups. This may suggest that the monocyte-stimulated release of the procoagulant tissue factor is inhibited by the corticosteroid, causing the blood to be relatively hypocoagulable.
Similar articles
-
Prothrombotic effects of endothelin-2 (ET-2).Agents Actions. 1993;39 Spec No:C104-5. doi: 10.1007/BF01972735. Agents Actions. 1993. PMID: 8273542
-
Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.J Natl Med Assoc. 1995 Sep;87(9):687-92. J Natl Med Assoc. 1995. PMID: 9583965 Free PMC article.
-
Deceptive prothrombin and activated partial thromboplastin times in alcoholic cirrhosis.J Natl Med Assoc. 1996 May;88(5):306-9. J Natl Med Assoc. 1996. PMID: 8667440 Free PMC article.
-
Are hypertensives hypercoagulable?J Natl Med Assoc. 1995 Jan;87(1):71-2. J Natl Med Assoc. 1995. PMID: 7869410 Free PMC article.
-
Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation.Shock. 2007 Oct;28(4):401-5. doi: 10.1097/shk.0b013e318063ed11. Shock. 2007. PMID: 17577134 Clinical Trial.
Cited by
-
Venous thrombosis and prothrombotic factors in inflammatory bowel disease.World J Gastroenterol. 2014 May 7;20(17):4857-72. doi: 10.3748/wjg.v20.i17.4857. World J Gastroenterol. 2014. PMID: 24803797 Free PMC article. Review.
-
Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.Drugs. 2004;64(18):2047-73. doi: 10.2165/00003495-200464180-00004. Drugs. 2004. PMID: 15341497 Review.
-
Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.Pediatr Nephrol. 2004 Nov;19(11):1232-6. doi: 10.1007/s00467-004-1584-z. Epub 2004 Aug 18. Pediatr Nephrol. 2004. PMID: 15322892
-
Effects of Thymoquinone on Urotensin-II and TGF-β1 Levels in Model of Osteonecrosis in Rats.Medicina (Kaunas). 2023 Oct 6;59(10):1781. doi: 10.3390/medicina59101781. Medicina (Kaunas). 2023. PMID: 37893499 Free PMC article.
-
Elevated risk of venous thromboembolic events in patients with inflammatory myopathies.Vasc Health Risk Manag. 2016 Jun 3;12:233-8. doi: 10.2147/VHRM.S75308. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27350751 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical